Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study

CONCLUSION: With this radiotherapy schedule, acute and late toxicity rates were acceptable with no adverse cosmesis. Local control, DFS, and OS were good.PMID:35796116 | DOI:10.3857/roj.2021.01053

Source: Cancer Control - July 7, 2022 Category: Cancer & Oncology Authors: Budhi Singh Yadav Shipra Gupta Divya Dahiya Ankita Gupta Arun Singh Oinam Source Type: research